KEAP1 and multiple sclerosis: Cysteine electrophilic Keap1-Nrf2 inhibitor that covalently binds to Keap1 can effectively enhance the antioxidant defense response, for example, dimethyl fumarate (Tecfidera) is clinically used to treat multiple sclerosis and psoriasis [39,40].